🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07203300
Active, not recruiting Not applicable

Obesity Prevention in School-aged Children

NCT07203300 · tracked via the Priya Life Science China tracker
Sponsor
Peking University
Phase
Not applicable
Started
2025-10-01
Last updated
2026-09-21

Condition(s) studied

Childhood Obesity Prevention

Investigational drug(s) / intervention(s)

multicomponent, tiered intervention

multicomponent, tiered intervention: this intervention is a multi-level collaborative health management system-a digital health platform with four core modules: the Health Education Module, the Growth Monitoring Module, the Health Behavior Module, and the Home-School Partnership Module. The platform facilitates collaboration among schools, families, and hospitals as follows: Schools utilize the platform to manage tasks outlined in health policies, such as delivering educational content, monitoring student activity and diet, and recording monthly height/weight measurements via the Growth Monitoring Module. Families access the platform to receive multi-format health education, set goals, and review personalized feedback. The Home-School Partnership Module also enables communication for motivational interviewing sessions conducted by professionals offline or by phone. Hospitals leverage the platform to provide professional guidance and medical support, ensuring interventions are medically sound.

Study summary

This cluster-randomized trial will develop and test an intervention technology for school-aged children. The program combines digital health technology and personalized behavior intervention through a WeChat platform.

Our main question is: Does this integrated approach improve obesity related outcomes and behaviors in children?

Investigator will:

* Compare children receiving the program with those receiving usual care.
* Track physical measures and health behaviors to measure effectiveness of intervention.
* Evaluate the program's safety, implementation process, and cost-effectiveness. Findings will determine if this approach should be expanded to more communities.

Eligibility

Sex
ALL
Min age
7 Years
Max age
9 Years
Healthy volunteers
No
Inclusion Criteria: * Schools will be selected based on the consent of primary leadership, demonstrated cooperation, and availability of necessary personnel (e.g., school health professionals). Classes will be limited to grades 2 and 3, with teachers showing strong willingness to collaborate. Both parental informed consent and child assent are required for participation. Exclusion Criteria: * Schools will be excluded if they cater to special populations (e.g., schools for children with disabilities), are involved in other obesity-related interventions within the specified timeframe, or plan to close or relocate within two years. Children will be excluded if they have histories of major organ diseases (e.g., cardiac, pulmonary, hepatic, or renal conditions), special diets (e.g., vegetarian), pathological eating disorders, physical limitations affecting activity, or obesity due to endocrine disorders or medication side effects.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking University Health Science Center Beijing China

More Peking University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07203300 on ClinicalTrials.gov ↗ ← All trials in China